| Literature DB >> 19034456 |
Bernadett Farago1, Gabor C Talian, Katalin Komlosi, Gergely Nagy, Timea Berki, Agnes Gyetvai, Zoltan Szekanecz, Zoltan Nyarady, Csaba G Kiss, Peter Nemeth, Laszlo Czirjak, Bela Melegh.
Abstract
The C1858T allele of the PTPN22 gene has been reported to confer risk for RA; but in some reports, the effect was restricted to RF- and/or anti-CCP-seropositive patients. Hungarian RA patients and matched controls were genotyped. The 1858T allele showed an increased prevalence in RA patients compared to controls. The 1858T allele represents a risk factor in the whole RA population (P = 0.001); an association was found both in RF-seropositive (P = 0.001) and anti-CCP-seropositive patients (P = 0.001), and in subjects with the combination of these factors (P = 0.002). In TT homozygotes, the estimated susceptibility to RA was more than double (OR = 5.04) of that seen in TC heterozygotes (OR = 1.89); the same gene dosage effect was observed in all seropositive RA subgroups. Our data show that the Hungarian RA patients belong to the populations in which the 1858T allele represents a susceptibility factor both in the RF- and/or anti-CCP-seropositive subjects, and the association exhibit a gene dosage dependency.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19034456 DOI: 10.1007/s00296-008-0771-9
Source DB: PubMed Journal: Rheumatol Int ISSN: 0172-8172 Impact factor: 2.631